Cannasouth Ltd
NZX:CBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cooper Companies Inc
NASDAQ:COO
|
US |
|
Praxis Precision Medicines Inc
NASDAQ:PRAX
|
US |
|
Zalando SE
XETRA:ZAL
|
DE |
Cannasouth Ltd
Other Current Liabilities
Cannasouth Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cannasouth Ltd
NZX:CBD
|
Other Current Liabilities
NZ$7.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Other Current Liabilities
NZ$7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
18%
|
CAGR 10-Years
9%
|
|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Other Current Liabilities
NZ$8.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Other Current Liabilities
NZ$30.2k
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Cannasouth Ltd
Glance View
Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.
See Also
What is Cannasouth Ltd's Other Current Liabilities?
Other Current Liabilities
7.4k
NZD
Based on the financial report for Dec 31, 2023, Cannasouth Ltd's Other Current Liabilities amounts to 7.4k NZD.
What is Cannasouth Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-49%
Over the last year, the Other Current Liabilities growth was -99%.